To further evaluate the roles of these genes in tumor recognition and immune response, we examined the expression levels of their corresponding ligands, Ulbp1 (ligand for NKG2D) and Cd48 (ligand for 2B4/SLAMF4), on BLMP1/2A cells and T-ALL tumor cells. This evidence concerns the gene CD48 and neoplasm.